It was worth noting that multiple subpopulations of TILs, presented in Figure 4D, were significantly different among the three clusters, revealing immune heterogeneity of TP53 mutation-associated metabolic gene profile in BC patients. This evidence concerns the gene TP53 and breast cancer.